Reuters logo
BRIEF-Pharma Mar submits MAA for Aplidin in Switzerland for multiple myeloma treatment
October 4, 2017 / 10:57 AM / in 2 months

BRIEF-Pharma Mar submits MAA for Aplidin in Switzerland for multiple myeloma treatment

Oct 4 (Reuters) - PHARMA MAR SA:

* SUBMITS MARKETING AUTHORISATION APPLICATION (MAA) FOR APLIDIN IN SWITZERLAND FOR TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA‍​ Source text: bit.ly/2xf24h3

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below